---
schema_version: "secwatch.filing_event.v1"
accession: "0000914121-22-004106"
form_type: "8-K"
ticker: "ANGO"
cik: "0001275187"
company_name: "ANGIODYNAMICS INC"
filed_at: "2022-10-06T23:59:59+00:00"
generated_at: "2026-06-23T04:56:14.758152+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AngioDynamics loses antitrust jury verdict against C.R. Bard in PICC market

## Summary
- Jury found Bard did not unlawfully restrain competition in U.S. PICC market following two-week trial in N.D.N.Y.
- AngioDynamics 'disappointed' with outcome, considering appeal.
- Verdict covers percutaneously inserted central catheters (PICCs), a vascular access device.
- No monetary damages or financial impact disclosed in filing.

## SEC filing metadata
- accession: 0000914121-22-004106
- form_type: 8-K
- ticker: ANGO
- cik: 0001275187
- company_name: ANGIODYNAMICS INC
- filed_at: 2022-10-06T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000091412122004106/0000914121-22-004106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000091412122004106/an58260107-8ki.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914121-22-004106
- JSON: https://secwatch.observer/filing/0000914121-22-004106.json
- Plain text: https://secwatch.observer/filing/0000914121-22-004106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.